Allergy Relief by is a Otc medication manufactured, distributed, or labeled by Dolgencorp, Inc. (DOLLAR GENERAL & REXALL). Drug facts, warnings, and ingredients follow.
if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.
liver or kidney disease. Your doctor should determine if you need a different dose.
an allergic reaction to this product occurs. Seek medical help right away.
adults and children 6 years and over | Take one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms. |
adults 65 years and over | ask a doctor |
children under 6 years of age | ask a doctor |
consumers with liver or kidney disease | ask a doctor |
Compare to the active ingredient of Zyrtec®*
All Day Allergy Relief
Cetirizine HCI Tablets,10 mg / Antihistamine
24-Hour Relief of:
Indoor & Outdoor Allergies
Tablets
*This product is not manufactured or distributed by McNeil Consumer Healthcare, distributor of Zyrtec®.
TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.
KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.
DISTRIBUTED BY DOLGENCORP, LLC
100 MISSION RIDGE
GOODLETTSVILLE, TN 37072
ALLERGY RELIEF
ALL DAY
cetirizine hcl tablet |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) (068331990) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ALLERGY RELIEF 98236984 not registered Live/Pending |
Dmytro Kononenko 2023-10-24 |
ALLERGY RELIEF 90457167 not registered Live/Pending |
American Textile Company, Inc. 2021-01-10 |
ALLERGY RELIEF 78838437 3358249 Live/Registered |
Meshbesher Health Corporation 2006-03-16 |
ALLERGY RELIEF 76619855 3066888 Live/Registered |
AMERICAN TEXTILE COMPANY 2004-11-09 |
ALLERGY RELIEF 74668018 not registered Dead/Abandoned |
NaturaLife Corporation 1995-05-01 |